Medicament for treatment of chronic bronchopneumonia

Abstract

The invention discloses a medicament for the treatment of chronic bronchopneumonia, belongs to the technical field of traditional Chinese medicines, and specifically relates to a medicament for the treatment of chronic bronchopneumonia. The invention provides the medicament for efficiently and rapidly treating chronic bronchopneumonia. The medicament for the treatment of chronic bronchopneumonia disclosed by the invention is characterized by being prepared from 2-5 parts of radix glycyrrhizae, 2-5 parts of cassia twig, 2-5 parts of ginger, 2-5 parts of ginseng, 3-8 parts of radix aucklandiae, 3-8 parts of rhizoma typhonii, 3-8 parts of hawthorn, and 3-8 parts of tortoise plastron.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine, in particular, the invention relates to a medicine for treating chronic bronchopneumonia. Background technique [0002] Bronchopneumonia, also known as lobular pneumonia, is the most common pneumonia in children. The incidence of bronchopneumonia virus in children with pneumonia in developing countries is significantly higher than that in developed countries, and the case fatality rate and death rate are higher than those in developed countries. Similar to other developing countries, infantile pneumonia is a serious disease that threatens the health of children in my country, ranking first in both morbidity and mortality. [0003] Pneumonia mostly occurs in winter and spring and when the climate changes suddenly. In some parts of southern China, the incidence is more frequent in summer. Indoor living is crowded, poorly ventilated, the air is dirty, and there are many pathog...

AI Technical Summary

Problems solved by technology

[0005] Chronic bronchopneumonia, difficult to ...